Australia, Jan. 9 -- Novo Nordisk A.S, owns the trademark (2483840) for 'Zilconyc' till June 11, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension.]
Type of Mark: Word
Date of Acceptance: Sept. 20, 2024
Registration Advertised: Jan. 8
For further details contact Novo Nordisk A.S .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2483840.
Disclaimer: Curated by HT Syndication.
